Implant Phenotype Modification Via GBR and ADM
Phenotype Modification Via Guided Bone Regeneration and Acellular Dermal Matrix Simultaneous to Delayed Implant Placement: A Double Arm Randomized Controlled Clinical Trial.
University of Michigan
40 participants
Jun 1, 2025
INTERVENTIONAL
Conditions
Summary
Single implant sites with bone loss can often be managed by bone grafting alone. The purpose of this study is to determine whether putting a soft tissue graft substitute over the bone graft will provide an increased benefit for improving the health, appearance, and stability of the bone and gums surrounding the implant.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will have a dental implant placed at a toothless site
Participants will receive guided bone regeneration at a toothless site with bone substitute and a collagen membrane.
Participants will receive guided bone regeneration at a toothless site with bone substitute and an acellular dermal matrix.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07082244